CTLA4 and hypertensive disorder: Mice treated with abatacept also had less circulating activated T cells and less immune infiltration into periadventitial fat.104 These findings establish T-cell costimulation as a necessary driver of vascular inflammation and represent a possible mechanism by which blockade of CTLA-4 may enhance cardiovascular inflammation, leading to hypertension.